Intrauterine devices (IUDs) refer to small T-shaped plastic or copper birth control devices to avoid pregnancies, that is inserted into the uterus so that it helps in stopping sperm from reaching in the fertilizing the egg. The size of this device is similar to that of a match stick and their arms are folded flat so that they fit properly in the uterus or injected to the uterus and they aim to inhibit the fertilization of an egg by causing changes such as toxicity or thickening of the cervical mucus.
The Global Intrauterine Contraceptive Devices Market was valued at $ 3.8 bn in 2018 and is forecasted to grow at a strong 3.5% CAGR between 2018 and 2026, resulting in 2026 global sales of $5Bn. Market-driven technological innovations leading to effective contraception and fewer side effects and increasing rate of unintended pregnancies are some of the components boosting the market. However, the risk of several health issues and insufficient emphasis during contraceptive consultations are some of the components hindering the market. Moreover, technological advancements for development such as reusable and postpartum IUDs and several governments and non-profit organizations are promoting the use of IUDs in confluence with educating the people will provide ample of opportunities in the market.
Intrauterine Contraceptive Devices Market depending on Type, hormonal intrauterine devices segment is dominated due to low failure rate as compared to copper IUD. This device consists of progestogen which is a form of a natural hormone known as progesterone. The main advantages are one of the most effective forms of reversible birth control and may experience lighter periods. The device's user needs to wait for two days of unguarded sex to prevent pregnancy.
The Global Intrauterine Contraceptive Devices Market is segmented on the basis of type, end-user, and region.
Based on the Type: Hormonal Intrauterine Devices and Copper Intrauterine Devices.
Based on the End-user: Hospitals, Gynecology Clinics, Community Health Care Centers and Other End Users.
Based on Region: North America, Asia-Pacific, Europe, and LAMEA. Among that the Asia Pacific is projected to witness high growth during the forecast period due to rising awareness among the woman population in the region is also dominating the growth of the Asia Pacific region. The countries like China and India are major contributor due to the stringent government directives and raising awareness regarding the use of devices. Moreover, the India government are supporting the R&D stringent government directives and raising awareness regarding the use of IUC devices projects in the IUD devices which dominated in further.
The key players of the Global Intrauterine Devices Market include CooperSurgical Inc, DKT International, Bayer AG, Prosan International BV, Eurogine S.L., Egemen International and etc...
Report Description: The report covers in-depth analysis of the Global Intrauterine Contraceptive Devices (IUD) Market. The report assesses the market products pipeline by Route of Administration (Injectables, Oral) by Therapeutic Class (Triptans, Ergot, NSAID's, CGRP antagonists and antibodies), by Treatment Class (Abortive, Prophylactic) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa). In addition, the report includes key insights on other development activities, including (but not limited to) – licensing (In and Out), collaborations, acquisitions, reimbursement, patent, and regulatory designations.
The report includes in-depth company profiles of key players in the Global Intrauterine Contraceptive Devices (IUD) Market. The company profile includes key information on the overview, financial highlights, product portfolio, business strategies, and key recent developments.
The report highlights information on emerging companies with potentially disruptive technologies and new market entrants.
Data Collation (Primary & Secondary)
In-house Estimation (Based on proprietary databases and Models)
Market-related information is assembled from both primary and secondary sources.
Primary sources involved participants from all global stakeholders such as experts from several related industries and suppliers that have been interviewed to obtain and verify critical information as well as to assess prospects of the market. The participants included are CXOs, VPs, and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.
Secondary sources include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications annual reports press releases along with paid sources such as Factiva, OneSource, Bloomberg among others.
Top-down and bottom-up approaches: The overall market size was used in the top-down approach to estimate the sizes of other individual submarkets (mentioned in the market segmentation by product, type of manufacturing, and disease) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained.